Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. QT Vascular claims victory in patent spat with Spectranetics
QT Vascular said it prevailed in a court case brought against it by Spectranetics subsidiary Angioscore over patent infringement issues with QT Vascular’s Chocolate PTA balloon catheter.
After a 7-day jury trial in the U.S. District Court for the Northern District of California, the jury ruled that QT Vascular’s Chocolate catheter did not infringe on any of the asserted claims brought against it, and claimed that certain claims of the asserted patent are invalid. Read more
2. Bard acquires full ownership of Kobayashi joint-venture Medicon
C.R. Bard said it agreed to fully acquire ownership of Osaka, Japan-based Medicon from its joint-venture partner Kobayashi Pharmaceutical Co.
The 2 companies have operated Medicon, which produces medical equipment and devices in the fields of urology and gastrointestinal medicine, since 1972. Read more
1. Haemonetics CEO Concannon steps down
Haemonetics said its CEO Brian Concannon resigned to pursue other opportunities and will be replaced by board member Ronald Gelbman, who will serve as interim CEO.
The company said Concannon will remain with Haemonetics through the end of October to “ensure a seamless transition,” while the board searches for a permanent replacement. Read more
